|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/60 | (2006.01) |
| A61K 31/616 | (2013.01) | ||
| A61K 31/616 | (2006.01) | ||
| A61K 9/0075 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3613421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19194560.9 |
| Date of filing the European patent application | 2013-03-15 | |
| (97) | Date of publication of the European application | 2020-02-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261740407 P | 2012-12-20 | US | |
| 201313791734 | 2013-03-08 | US |
| (72) |
YADIDI, Kambiz , US
|
| (73) |
Vectura Inc. ,
677 Washington Boulevard, Stamford, CT 06901,
US
|
| (54) | ACETYLSALICYLIC ACID FOR REDUCING THE RISK OF A THROMBOEMBOLIC EVENT |
| ACETYLSALICYLIC ACID FOR REDUCING THE RISK OF A THROMBOEMBOLIC EVENT |